Innospec (IOSP) Competitors $118.25 +1.56 (+1.34%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IOSP vs. LTHM, GCP, PQG, NGVT, GRA, CE, BCPC, NEU, FUL, and ASHShould you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Livent (LTHM), GCP Applied Technologies (GCP), PQ Group (PQG), Ingevity (NGVT), W. R. Grace & Co. (GRA), Celanese (CE), Balchem (BCPC), NewMarket (NEU), H.B. Fuller (FUL), and Ashland (ASH). Innospec vs. Livent GCP Applied Technologies PQ Group Ingevity W. R. Grace & Co. Celanese Balchem NewMarket H.B. Fuller Ashland Livent (NYSE:LTHM) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Is LTHM or IOSP more profitable? Livent has a net margin of 40.77% compared to Innospec's net margin of 7.68%. Livent's return on equity of 25.60% beat Innospec's return on equity.Company Net Margins Return on Equity Return on Assets Livent40.77% 25.60% 18.40% Innospec 7.68%13.33%9.18% Do institutionals & insiders have more ownership in LTHM or IOSP? 96.8% of Livent shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 1.2% of Livent shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, LTHM or IOSP? Livent has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Innospec has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Which has stronger earnings and valuation, LTHM or IOSP? Livent has higher earnings, but lower revenue than Innospec. Livent is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivent$813.20M3.65$273.50M$1.799.22Innospec$1.95B1.51$139.10M$5.7320.64 Does the media prefer LTHM or IOSP? In the previous week, Innospec had 4 more articles in the media than Livent. MarketBeat recorded 4 mentions for Innospec and 0 mentions for Livent. Innospec's average media sentiment score of 0.60 beat Livent's score of 0.00 indicating that Innospec is being referred to more favorably in the news media. Company Overall Sentiment Livent Neutral Innospec Positive Does the MarketBeat Community believe in LTHM or IOSP? Innospec received 208 more outperform votes than Livent when rated by MarketBeat users. Likewise, 65.93% of users gave Innospec an outperform vote while only 50.21% of users gave Livent an outperform vote. CompanyUnderperformOutperformLiventOutperform Votes12150.21% Underperform Votes12049.79% InnospecOutperform Votes32965.93% Underperform Votes17034.07% Do analysts recommend LTHM or IOSP? Livent presently has a consensus price target of $16.67, indicating a potential upside of 0.95%. Given Livent's stronger consensus rating and higher possible upside, equities research analysts plainly believe Livent is more favorable than Innospec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Livent 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67Innospec 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryLivent beats Innospec on 9 of the 17 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Innospec News Delivered to You Automatically Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOSP vs. The Competition Export to ExcelMetricInnospecChemicals & allied products IndustryMaterials SectorNASDAQ ExchangeMarket Cap$2.91B$3.84B$2.82B$8.89BDividend Yield1.35%2.87%5.26%4.06%P/E Ratio20.6414.42108.2913.30Price / Sales1.5125.26591,136.9581.01Price / Cash15.1411.0023.4336.03Price / Book2.362.653.325.74Net Income$139.10M$244.18M$149.36M$225.93M7 Day Performance-2.95%-0.66%0.62%-1.32%1 Month Performance6.27%-3.48%1.39%0.60%1 Year Performance10.96%13.34%27.42%26.23% Innospec Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOSPInnospec3.6901 of 5 stars$118.25+1.3%N/A+9.0%$2.91B$1.95B20.642,400Ex-DividendLTHMLivent0.5997 of 5 stars$16.51flat$16.67+0.9%N/A$2.97B$813.20M9.221,350GCPGCP Applied TechnologiesN/A$32.01flatN/AN/A$2.37B$970.10M228.641,800PQGPQ GroupN/AN/AN/AN/A$2.14B$1.11B-10.872,274NGVTIngevity2.5698 of 5 stars$46.22+0.5%$52.17+12.9%+15.0%$1.67B$1.69B0.001,700Positive NewsGRAW. R. Grace & Co.1.6566 of 5 stars$69.99flatN/AN/A$4.64B$1.73B26.514,000Analyst ForecastCECelanese4.9618 of 5 stars$72.86+0.9%$120.59+65.5%-44.2%$7.89B$10.48B7.3312,410Analyst ForecastHigh Trading VolumeBCPCBalchem4.1793 of 5 stars$178.03+0.3%$190.00+6.7%+43.5%$5.79B$922.44M47.861,302Positive NewsNEUNewMarket2.074 of 5 stars$538.36+0.7%N/A+4.2%$5.13B$2.70B11.962,000Positive NewsFULH.B. Fuller4.2653 of 5 stars$74.56+1.2%$97.67+31.0%-1.6%$4.03B$3.51B23.017,200ASHAshland4.9307 of 5 stars$76.23-0.2%$103.29+35.5%-2.7%$3.72B$2.11B22.763,800Dividend AnnouncementAnalyst Forecast Related Companies and Tools Related Companies LTHM Alternatives GCP Alternatives PQG Alternatives NGVT Alternatives GRA Alternatives CE Alternatives BCPC Alternatives NEU Alternatives FUL Alternatives ASH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IOSP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innospec Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innospec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
